Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Solid Malignancies × tremelimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignancies 1 Neoplasms 1 Lung Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02537418 2025-08-19

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Canadian Cancer Trials Group

Phase 1 Active not recruiting

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡